Tablets
-
Subject Areas on Research
- "Take your pill": the role and fantasy of pills in modern medicine.
- A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
- A new objective measurement of esophageal lumen patency.
- A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258).
- Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
- Comparison of Glucosamine Absorption After Administration of Oral Liquid, Chewable, and Tablet Formulations to Dogs.
- Determination of sulfadiazine and sulfamethoxazole by capillary electrophoresis with end-column electrochemical detection.
- Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
- Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
- Efficacy of traditional chinese medicine in functional constipation.
- Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
- Evaluation of a sol-gel derived carbon composite electrode as an amperometric detector for capillary electrophoresis.
- Everolimus tablets for patients with subependymal giant cell astrocytoma.
- Labor prior to cesarean delivery associated with higher post-discharge opioid consumption.
- Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder.
- Oral ondansetron pharmacokinetics: the effect of chemotherapy.
- PA tablets: investigational compounds combining aspirin and omeprazole for cardioprotection.
- Pharmacobezoar in a patient on an oral phosphate binder.
- Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
- Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass.
- Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.